Prevalence of biliary acid malabsorption in patients with chronic diarrhoea of functional characteristics: a prospective study

Prevalence of biliary acid malabsorption in patients with chronic diarrhoea of functional characteristics: a prospective study

Abstract Background Bile acid malabsorption occurs in up to one third of patients with chronic diarrhoea of functional characteristics. The gold standard test for its diagnosis is the 75Selenium homocholic acid taurine (75SeHCAT) test. The aim of this work is to confirm previous data suggesting that...

Full description

Bibliographic Details
Main Authors:	Virginia Flores, Helena Martínez-Lozano, Federico Bighelli, Javier Orcajo, Javier García-Lledó, Juan Carlos Alonso-Farto, Luis Menchén
Format:	Article
Language:	English
Published:	BMC 2021-02-01
Series:	BMC Gastroenterology
Subjects:	Bile acid diarrhoea Bile acid malabsorption SeHCAT Functional diarrhoea Irritable bowel syndrome Cholestyramine
Online Access:	https://doi.org/10.1186/s12876-021-01637-4

Similar Items

High prevalence of primary bile acid diarrhoea in patients with functional diarrhoea and irritable bowel syndrome-diarrhoea, based on Rome III and Rome IV criteria
by: Mohamed G. Shiha, et al.
Published: (2020-08-01)

SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis
by: R Riemsma, et al.
Published: (2013-12-01)

Cholestyramine treatment in two dogs with presumptive bile acid diarrhoea: a case report
by: L. Toresson, et al.
Published: (2021-01-01)

SeHCAT (tauroselcholic [75selenium] acid) for the investigation of bile acid diarrhoea in adults: a systematic review and cost-effectiveness analysis
by: Marie Westwood, et al.
Published: (2022-11-01)

Manipulating the Microbiome: An Alternative Treatment for Bile Acid Diarrhoea
by: Evette B. M. Hillman, et al.
Published: (2021-04-01)

The impact of treatment with bile acid sequestrants on quality of life in patients with bile acid diarrhoea
by: Aditi Kumar, et al.
Published: (2022-07-01)

Is bile acid malabsorption really a common feature of Crohn’s disease or is it simply a consequence of ileal resection?
by: Eva eKunstar, et al.
Published: (2011-08-01)

Efficacy of bile salt hydrolase synthesizing probiotic bacteria in the treatment of irritable bowel syndrome with diarrhea
by: S.P. Polishchuk, et al.
Published: (2023-06-01)

The analysis of gut microbiota in patients with bile acid diarrhoea treated with colesevelam
by: Aditi Kumar, et al.
Published: (2023-03-01)

Congenital diarrhoea in a neonate with hypernatraemia and dehydration
by: Ammara Kaleem, et al.
Published: (2023-10-01)

Bile Acid Malabsorption as a Consequence of Cancer Treatment: Prevalence and Management in the National Leading Centre
by: Caroline Gee, et al.
Published: (2021-12-01)

Vortioxetine treatment for major depressive disorder with the co-morbidity of irritable bowel syndrome with diarrhoea: a case report
by: Orkun Aydin, et al.
Published: (2018-01-01)

The gut virome in Irritable Bowel Syndrome differs from that of controls
by: S. Coughlan, et al.
Published: (2021-01-01)

Methods for diagnosing bile acid malabsorption: a systematic review
by: Ivan Lyutakov, et al.
Published: (2019-11-01)

Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights
by: Giusi Desirè Sciumè, et al.
Published: (2023-09-01)

Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?
by: Dwaipayan Sarathi Chakraborty, et al.
Published: (2019-01-01)

Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia
by: V. T. Ivashkin, et al.
Published: (2022-01-01)

Alterations of bile acid metabolism in patients with functional bowel disorders: a case-control study
by: Serhii Polishchuk, et al.
Published: (2023-11-01)

What Are the Pearls and Pitfalls of the Dietary Management for Chronic Diarrhoea?
by: Leigh O’Brien, et al.
Published: (2021-04-01)

Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial
by: David Gunn, et al.
Published: (2019-08-01)

CYP7A1 promoter polymorphism −203A>C affects bile salt synthesis rate in patients after ileal resection
by: Martin Leníček, et al.
Published: (2008-12-01)

Antagonism Between Gut Ruminococcus gnavus and Akkermansia muciniphila Modulates the Progression of Chronic Hepatitis BSummary
by: Huey-Huey Chua, et al.
Published: (2024-01-01)

Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea
by: Cornelia M. van Schewick, et al.
Published: (2020-07-01)

A blinded randomised controlled trial to determine the effect of enteric coating on enzyme treatment for canine exocrine pancreatic efficiency
by: Mas Aran, et al.
Published: (2012-07-01)

Treatment patterns of childhood diarrhoea in rural Uganda: a cross-sectional survey
by: Löfgren Jenny, et al.
Published: (2012-09-01)

The use of metronidazole in adult dogs with acute onset, uncomplicated, diarrhoea
by: Emma Rogers-Smith
Published: (2021-12-01)

Inflammation‐induced cholestasis in cancer cachexia
by: Morgane M. Thibaut, et al.
Published: (2021-02-01)

Effects of Bile Acid Modulation by Dietary Fat, Cholecystectomy, and Bile Acid Sequestrant on Energy, Glucose, and Lipid Metabolism and Gut Microbiota in Mice
by: Sunmin Park, et al.
Published: (2022-05-01)

An electron microscopic and functional study of very low density lipoproteins in intestinal lymph
by: Robert K. Ockner, et al.
Published: (1970-07-01)

Effects of bile acid sequestration on hepatic steatosis in obese mice
by: Nancy Solís, et al.
Published: (2014-01-01)

Characterization of AQPs in mouse, rat and human colon and their selective regulation by bile acids
by: Jonathan Yde, et al.
Published: (2016-10-01)

Is the Incidence of Clostridium difficile in Nosocomial Diarrhoea Underestimated?
by: Özer AKGÜL, et al.
Published: (2018-06-01)

Randomized controlled trial of cholestyramine and hydrotalcite to eliminate bile for capsule endoscopy
by: Chen Hong-Bin, et al.
Published: (2016-01-01)

Bile acid dysmetabolism in inflammatory bowel diseases
by: Daria A. Kuznetsova, et al.
Published: (2023-05-01)

Biliary secretion and excretion in health and disease: Current concepts
by: Alan F Hofmann
Published: (2007-01-01)

Randomised, double-blind, placebo controlled multi-centre study to assess the efficacy, tolerability and safety of Enterosgel® in the treatment of irritable bowel syndrome with diarrhoea (IBS-D) in adults
by: Anu Kemppinen, et al.
Published: (2020-01-01)

Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome
by: Jingze Yang, et al.
Published: (2021-11-01)

Could the Microbiota Be a Predictive Factor for the Clinical Response to Probiotic Supplementation in IBS-D? A Cohort Study
by: Justine Marchix, et al.
Published: (2023-01-01)

Pathophysiology and Clinical Management of Bile Acid Diarrhea
by: Giovanni Marasco, et al.
Published: (2022-05-01)

Olmesartan-Associated Enteropathy: An Unexpected Cause of Chronic Diarrhoea
by: Mónica Martins Teixeira, et al.
Published: (2019-04-01)